Good afternoon :)
$
₹
M

Medline Inc. Class A Common Stock

MDLN

NASDAQ
M

Medline Inc. Class A Common Stock

MDLN

NASDAQ
$40.3818.46% (+6.29)
$
₹
$40.3818.46% (+6.29)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Instruments & Supplies

Large Cap

With a market cap of $45.2B the stock is ranked 355

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

80.07
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

2.43
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$0.42
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

2.32%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 27 analysts reports

Buy
23 analysts
Hold
4 analysts
Sell
0 analyst

Price Upside

+9.81%

Earnings Growth

+122.86%

Rev. Growth

+9.83%

See Detailed Forecast

Company Profile

Company Profile

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
West Pharmaceutical Services Inc
WST
West Pharmaceutical Services Inc
P/E Ratio
45.77
45.77
1Y Return
42.57%
42.57%
Buy Reco %
93.75
93.75
The Cooper Companies, Inc
COO
The Cooper Companies, Inc
P/E Ratio
21.06
21.06
1Y Return
11.94%
11.94%
Buy Reco %
35.29
35.29
Align Technology Inc
ALGN
Align Technology Inc
P/E Ratio
22.46
22.46
1Y Return
11.72%
11.72%
Buy Reco %
50.00
50.00
Bausch + Lomb Corp
BLCO
Bausch + Lomb Corp
P/E Ratio
—
—
1Y Return
33.53%
33.53%
Buy Reco %
46.66
46.66
Lantheus Holdings Inc
LNTH
Lantheus Holdings Inc
P/E Ratio
24.34
24.34
1Y Return
75.25%
75.25%
Buy Reco %
20.00
20.00
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

2026
Current$40.35Baseline
Analyst Target - 1 year
Target$44.31+9.81%

All values in $

20232024202520262027$39.42$42.53$45.63Target+9.81%
2026
Current$40.35Baseline
Analyst Target - 1 year
Target$44.31+9.81%

All values in $

Revenue Forecast

Revenue Forecast

Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 9.83% growth, versus a trailing 3-year CAGR of 9.85%.

2025
Current$28.43Baseline
Forecast for Dec 2026
High$31.48+10.73%
Average$31.22+9.83%
Low$31.10+9.39%

All values in $ Billion

2022202320242025202621.4423.2325.5028.43Low+9.39%Average+9.83%High+10.73%
2025
Current$28.43Baseline
Forecast for Dec 2026
High$31.48+10.73%
Average$31.22+9.83%
Low$31.10+9.39%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

2025
Current$0.69Baseline
Forecast for Dec 2026
High$1.82+163.77%
Average$1.54+122.86%
Low$1.36+97.41%

All values in $

20222023202420252026N/AN/AN/A0.69Low+97.41%Average+122.86%High+163.77%
2025
Current$0.69Baseline
Forecast for Dec 2026
High$1.82+163.77%
Average$1.54+122.86%
Low$1.36+97.41%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

7.1
0.3
7.7
0.1
7.3
0.1
7.6
0
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue6.186.38-6.646.887.117.787.357.68
Net Income0.290.32-0.320.330.320.180.120.06
Net Profit Margin4.72%5.07%-4.84%4.83%4.52%2.31%1.75%0.78%
See CostsAll values in $ Billion

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Instruments & Supplies

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Medline Inc. Class A Common Stock 80.072.43-
West Pharmaceutical Services Inc45.779.683.21
The Cooper Companies, Inc21.061.350.55
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare MDLN with any stock or ETF
Compare MDLN with any stock or ETF
Comparing from
MDLN
WST
COO
Loading...

Frequently asked questions

  1. Medline Inc. Class A Common Stock (MDLN) share price today is $40.38 as of November 5, 2026 at 2:29 AM IST. The stock touched a day high of $40.67 and a day low of $37.39.

  2. Medline Inc. Class A Common Stock stock trades on NASDAQ under the ticker symbol MDLN.

  3. Medline Inc. Class A Common Stock's market capitalization is $45.24B as of November 5, 2026 at 2:29 AM IST.

  4. Medline Inc. Class A Common Stock's price-to-earnings (P/E) ratio is 80.07 as of November 4, 2026.

  5. Medline Inc. Class A Common Stock's price-to-book (P/B) ratio is 2.43 as of November 4, 2026.

  6. Yes, You can buy Medline Inc. Class A Common Stock shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Medline Inc. Class A Common Stock shares in three steps: 1. Search Medline Inc. Class A Common Stock on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Medline Inc. Class A Common Stock trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Medline Inc. Class A Common Stock (MDLN) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.2476 shares at the current price of $40.38.

Loading...